Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 292 entries
Sorted by: Best Match Show Resources per page
Effects of electric current on individual graphene oxide sheets combining in situ transmission electron microscopy and Raman spectroscopy.

Nanotechnology

Martín G, Varea A, Cirera A, Estradé S, Peiró F, Cornet A.
PMID: 29664411
Nanotechnology. 2018 Jul 13;29(28):285702. doi: 10.1088/1361-6528/aabed2. Epub 2018 Apr 17.

Graphene oxide (GO) is currently the object of extensive research because of its potential use in mass production of graphene-based materials, but also due to its tunability which holds great promise for new nanoscale electronic devices and sensors. To...

Cite
Martín G, Varea A, Cirera A, et al. Effects of electric current on individual graphene oxide sheets combining in situ transmission electron microscopy and Raman spectroscopy. Nanotechnology. 2018;29(28):285702doi: 10.1088/1361-6528/aabed2.
Martín, G., Varea, A., Cirera, A., Estradé, S., Peiró, F., & Cornet, A. (2018). Effects of electric current on individual graphene oxide sheets combining in situ transmission electron microscopy and Raman spectroscopy. Nanotechnology, 29(28), 285702. https://doi.org/10.1088/1361-6528/aabed2
Martín, Gemma, et al. "Effects of electric current on individual graphene oxide sheets combining in situ transmission electron microscopy and Raman spectroscopy." Nanotechnology vol. 29,28 (2018): 285702. doi: https://doi.org/10.1088/1361-6528/aabed2
Martín G, Varea A, Cirera A, Estradé S, Peiró F, Cornet A. Effects of electric current on individual graphene oxide sheets combining in situ transmission electron microscopy and Raman spectroscopy. Nanotechnology. 2018 Jul 13;29(28):285702. doi: 10.1088/1361-6528/aabed2. Epub 2018 Apr 17. PMID: 29664411.
Copy Download .nbib Format: NLM
Low-Power, High-Performance, Non-volatile Inkjet-Printed HfO.

ACS applied materials & interfaces

Vescio G, Martín G, Crespo-Yepes A, Claramunt S, Alonso D, López-Vidrier J, Estradé S, Porti M, Rodríguez R, Peiró F, Cornet A, Cirera A, Nafría M.
PMID: 31180626
ACS Appl Mater Interfaces. 2019 Jul 03;11(26):23659-23666. doi: 10.1021/acsami.9b01731. Epub 2019 Jun 21.

Low-power, high-performance metal-insulator-metal (MIM) non-volatile resistive memories based on HfO

Cite
Vescio G, Martín G, Crespo-Yepes A, et al. Low-Power, High-Performance, Non-volatile Inkjet-Printed HfO. ACS Appl Mater Interfaces. 2019;11(26):23659-23666doi: 10.1021/acsami.9b01731.
Vescio, G., Martín, G., Crespo-Yepes, A., Claramunt, S., Alonso, D., López-Vidrier, J., Estradé, S., Porti, M., Rodríguez, R., Peiró, F., Cornet, A., Cirera, A., & Nafría, M. (2019). Low-Power, High-Performance, Non-volatile Inkjet-Printed HfO. ACS applied materials & interfaces, 11(26), 23659-23666. https://doi.org/10.1021/acsami.9b01731
Vescio, Giovanni, et al. "Low-Power, High-Performance, Non-volatile Inkjet-Printed HfO." ACS applied materials & interfaces vol. 11,26 (2019): 23659-23666. doi: https://doi.org/10.1021/acsami.9b01731
Vescio G, Martín G, Crespo-Yepes A, Claramunt S, Alonso D, López-Vidrier J, Estradé S, Porti M, Rodríguez R, Peiró F, Cornet A, Cirera A, Nafría M. Low-Power, High-Performance, Non-volatile Inkjet-Printed HfO. ACS Appl Mater Interfaces. 2019 Jul 03;11(26):23659-23666. doi: 10.1021/acsami.9b01731. Epub 2019 Jun 21. PMID: 31180626.
Copy Download .nbib Format: NLM
Systemic lupus erythematosus: state of the art on clinical practice guidelines.

RMD open

Tamirou F, Arnaud L, Talarico R, Scirè CA, Alexander T, Amoura Z, Avcin T, Bortoluzzi A, Cervera R, Conti F, Cornet A, Devilliers H, Doria A, Frassi M, Fredi M, Govoni M, Houssiau F, Lladò A, Macieira C, Martin T, Massaro L, Moraes-Fontes MF, Pamfil C, Paolino S, Tani C, Tas SW, Tektonidou M, Tincani A, Van Vollenhoven RF, Bombardieri S, Burmester G, Eurico FJ, Galetti I, Hachulla E, Mueller-Ladner U, Schneider M, Smith V, Cutolo M, Mosca M, Costedoat-Chalumeau N.
PMID: 30564454
RMD Open. 2018 Nov 27;4(2):e000793. doi: 10.1136/rmdopen-2018-000793. eCollection 2018.

Systemic lupus erythematosus (SLE) is the paradigm of systemic autoimmune diseases characterised by a wide spectrum of clinical manifestations with an unpredictable relapsing-remitting course. The aim of the present work was to identify current available clinical practice guidelines (CPGs)...

Cite
Tamirou F, Arnaud L, Talarico R, et al. Systemic lupus erythematosus: state of the art on clinical practice guidelines. RMD Open. 2018;4(2):e000793doi: 10.1136/rmdopen-2018-000793.
Tamirou, F., Arnaud, L., Talarico, R., Scirè, C. A., Alexander, T., Amoura, Z., Avcin, T., Bortoluzzi, A., Cervera, R., Conti, F., Cornet, A., Devilliers, H., Doria, A., Frassi, M., Fredi, M., Govoni, M., Houssiau, F., Lladò, A., Macieira, C., Martin, T., Massaro, L., Moraes-Fontes, M. F., Pamfil, C., Paolino, S., Tani, C., Tas, S. W., Tektonidou, M., Tincani, A., Van Vollenhoven, R. F., Bombardieri, S., Burmester, G., Eurico, F. J., Galetti, I., Hachulla, E., Mueller-Ladner, U., Schneider, M., Smith, V., Cutolo, M., Mosca, M., & Costedoat-Chalumeau, N. (2018). Systemic lupus erythematosus: state of the art on clinical practice guidelines. RMD open, 4(2), e000793. https://doi.org/10.1136/rmdopen-2018-000793
Tamirou, Farah, et al. "Systemic lupus erythematosus: state of the art on clinical practice guidelines." RMD open vol. 4,2 (2018): e000793. doi: https://doi.org/10.1136/rmdopen-2018-000793
Tamirou F, Arnaud L, Talarico R, Scirè CA, Alexander T, Amoura Z, Avcin T, Bortoluzzi A, Cervera R, Conti F, Cornet A, Devilliers H, Doria A, Frassi M, Fredi M, Govoni M, Houssiau F, Lladò A, Macieira C, Martin T, Massaro L, Moraes-Fontes MF, Pamfil C, Paolino S, Tani C, Tas SW, Tektonidou M, Tincani A, Van Vollenhoven RF, Bombardieri S, Burmester G, Eurico FJ, Galetti I, Hachulla E, Mueller-Ladner U, Schneider M, Smith V, Cutolo M, Mosca M, Costedoat-Chalumeau N. Systemic lupus erythematosus: state of the art on clinical practice guidelines. RMD Open. 2018 Nov 27;4(2):e000793. doi: 10.1136/rmdopen-2018-000793. eCollection 2018. PMID: 30564454; PMCID: PMC6269635.
Copy Download .nbib Format: NLM
Ligand Locking on Quantum Dot Surfaces via a Mild Reactive Surface Treatment.

Journal of the American Chemical Society

Loiudice A, Segura Lecina O, Bornet A, Luther JM, Buonsanti R.
PMID: 34375098
J Am Chem Soc. 2021 Aug 25;143(33):13418-13427. doi: 10.1021/jacs.1c06777. Epub 2021 Aug 10.

At the outermost surface of colloidal QDs are organic surface ligands which dynamically bind and release in solution to control the growth kinetics, control the size/shape of the crystals, passivate surface states, and provide colloidal stability through favorable interactions...

Cite
Loiudice A, Segura Lecina O, Bornet A, et al. Ligand Locking on Quantum Dot Surfaces via a Mild Reactive Surface Treatment. J Am Chem Soc. 2021;143(33):13418-13427doi: 10.1021/jacs.1c06777.
Loiudice, A., Segura Lecina, O., Bornet, A., Luther, J. M., & Buonsanti, R. (2021). Ligand Locking on Quantum Dot Surfaces via a Mild Reactive Surface Treatment. Journal of the American Chemical Society, 143(33), 13418-13427. https://doi.org/10.1021/jacs.1c06777
Loiudice, Anna, et al. "Ligand Locking on Quantum Dot Surfaces via a Mild Reactive Surface Treatment." Journal of the American Chemical Society vol. 143,33 (2021): 13418-13427. doi: https://doi.org/10.1021/jacs.1c06777
Loiudice A, Segura Lecina O, Bornet A, Luther JM, Buonsanti R. Ligand Locking on Quantum Dot Surfaces via a Mild Reactive Surface Treatment. J Am Chem Soc. 2021 Aug 25;143(33):13418-13427. doi: 10.1021/jacs.1c06777. Epub 2021 Aug 10. PMID: 34375098.
Copy Download .nbib Format: NLM
Participating in a vaccine trial for COVID-19 in Senegal: trust and information.

Human vaccines & immunotherapeutics

Ridde V, Ba MF, Gaye I, Diallo AI, Bonnet E, Faye A.
PMID: 34280070
Hum Vaccin Immunother. 2021 Nov 02;17(11):3907-3912. doi: 10.1080/21645515.2021.1951097. Epub 2021 Jul 19.

This research aims to understand the level and determinants of people's willingness to participate in a vaccine trial for COVID-19 in Senegal. We conducted a telephone survey among a marginal quota sample of 607 people over 18 years of...

Cite
Ridde V, Ba MF, Gaye I, et al. Participating in a vaccine trial for COVID-19 in Senegal: trust and information. Hum Vaccin Immunother. 2021;17(11):3907-3912doi: 10.1080/21645515.2021.1951097.
Ridde, V., Ba, M. F., Gaye, I., Diallo, A. I., Bonnet, E., & Faye, A. (2021). Participating in a vaccine trial for COVID-19 in Senegal: trust and information. Human vaccines & immunotherapeutics, 17(11), 3907-3912. https://doi.org/10.1080/21645515.2021.1951097
Ridde, V, et al. "Participating in a vaccine trial for COVID-19 in Senegal: trust and information." Human vaccines & immunotherapeutics vol. 17,11 (2021): 3907-3912. doi: https://doi.org/10.1080/21645515.2021.1951097
Ridde V, Ba MF, Gaye I, Diallo AI, Bonnet E, Faye A. Participating in a vaccine trial for COVID-19 in Senegal: trust and information. Hum Vaccin Immunother. 2021 Nov 02;17(11):3907-3912. doi: 10.1080/21645515.2021.1951097. Epub 2021 Jul 19. PMID: 34280070.
Copy Download .nbib Format: NLM
Digital health in oncology in Africa: A scoping review and cross-sectional survey.

International journal of medical informatics

Kabukye JK, Kakungulu E, Keizer N, Cornet R.
PMID: 34929545
Int J Med Inform. 2021 Dec 11;158:104659. doi: 10.1016/j.ijmedinf.2021.104659. Epub 2021 Dec 11.

BACKGROUND: Low- and middle-income countries, especially in Africa, face a growing cancer burden. Adoption of digital health solutions has the potential to improve cancer care delivery and research in these countries. However, the extent of implementation and the impact...

Cite
Kabukye JK, Kakungulu E, Keizer N, et al. Digital health in oncology in Africa: A scoping review and cross-sectional survey. Int J Med Inform. 2021;158:104659doi: 10.1016/j.ijmedinf.2021.104659.
Kabukye, J. K., Kakungulu, E., Keizer, N., & Cornet, R. (2021). Digital health in oncology in Africa: A scoping review and cross-sectional survey. International journal of medical informatics, 158104659. https://doi.org/10.1016/j.ijmedinf.2021.104659
Kabukye, Johnblack K, et al. "Digital health in oncology in Africa: A scoping review and cross-sectional survey." International journal of medical informatics vol. 158 (2021): 104659. doi: https://doi.org/10.1016/j.ijmedinf.2021.104659
Kabukye JK, Kakungulu E, Keizer N, Cornet R. Digital health in oncology in Africa: A scoping review and cross-sectional survey. Int J Med Inform. 2021 Dec 11;158:104659. doi: 10.1016/j.ijmedinf.2021.104659. Epub 2021 Dec 11. PMID: 34929545.
Copy Download .nbib Format: NLM
Second- or third-generation tyrosine kinase inhibitors in first-line treatment of chronic myeloid leukemia in general population: Is there a real benefit?.

Cancer medicine

Canet J, Cony-Makhoul P, Orazio S, Cornet E, Troussard X, Maynadié M, Étienne G, Monnereau A.
PMID: 34551198
Cancer Med. 2021 Oct;10(20):6959-6970. doi: 10.1002/cam4.4186. Epub 2021 Sep 22.

INTRODUCTION: Since 2009, multiple randomized trials have shown faster and deeper responses in CML patients treated with new-generation TKI (NG-TKI) compared to those treated with imatinib (IM). Are the same results observed in the general population?MATERIALS AND METHODS: Patients...

Cite
Canet J, Cony-Makhoul P, Orazio S, et al. Second- or third-generation tyrosine kinase inhibitors in first-line treatment of chronic myeloid leukemia in general population: Is there a real benefit?. Cancer Med. 2021;10(20):6959-6970doi: 10.1002/cam4.4186.
Canet, J., Cony-Makhoul, P., Orazio, S., Cornet, E., Troussard, X., Maynadié, M., Étienne, G., & Monnereau, A. (2021). Second- or third-generation tyrosine kinase inhibitors in first-line treatment of chronic myeloid leukemia in general population: Is there a real benefit?. Cancer medicine, 10(20), 6959-6970. https://doi.org/10.1002/cam4.4186
Canet, Jim, et al. "Second- or third-generation tyrosine kinase inhibitors in first-line treatment of chronic myeloid leukemia in general population: Is there a real benefit?." Cancer medicine vol. 10,20 (2021): 6959-6970. doi: https://doi.org/10.1002/cam4.4186
Canet J, Cony-Makhoul P, Orazio S, Cornet E, Troussard X, Maynadié M, Étienne G, Monnereau A. Second- or third-generation tyrosine kinase inhibitors in first-line treatment of chronic myeloid leukemia in general population: Is there a real benefit?. Cancer Med. 2021 Oct;10(20):6959-6970. doi: 10.1002/cam4.4186. Epub 2021 Sep 22. PMID: 34551198; PMCID: PMC8525157.
Copy Download .nbib Format: NLM
Complete Genome Sequence of Staphylococcus epidermidis PH1-28, Isolated from the Forehead of a Hyperseborrheic Donor.

Microbiology resource announcements

Hilaire P, Landemaine L, Contreras S, Blanquart-Goudezeune H, Siguier P, Cornet F, Chiapello H, Loux V, Clavaud C, Morand SC.
PMID: 33664152
Microbiol Resour Announc. 2021 Mar 04;10(9). doi: 10.1128/MRA.00165-21.

We report the complete genome sequence of

Cite
Hilaire P, Landemaine L, Contreras S, et al. Complete Genome Sequence of Staphylococcus epidermidis PH1-28, Isolated from the Forehead of a Hyperseborrheic Donor. Microbiol Resour Announc. 2021;10(9)doi: 10.1128/MRA.00165-21.
Hilaire, P., Landemaine, L., Contreras, S., Blanquart-Goudezeune, H., Siguier, P., Cornet, F., Chiapello, H., Loux, V., Clavaud, C., & Morand, S. C. (2021). Complete Genome Sequence of Staphylococcus epidermidis PH1-28, Isolated from the Forehead of a Hyperseborrheic Donor. Microbiology resource announcements, 10(9), . https://doi.org/10.1128/MRA.00165-21
Hilaire, Pascal, et al. "Complete Genome Sequence of Staphylococcus epidermidis PH1-28, Isolated from the Forehead of a Hyperseborrheic Donor." Microbiology resource announcements vol. 10,9 (2021). doi: https://doi.org/10.1128/MRA.00165-21
Hilaire P, Landemaine L, Contreras S, Blanquart-Goudezeune H, Siguier P, Cornet F, Chiapello H, Loux V, Clavaud C, Morand SC. Complete Genome Sequence of Staphylococcus epidermidis PH1-28, Isolated from the Forehead of a Hyperseborrheic Donor. Microbiol Resour Announc. 2021 Mar 04;10(9). doi: 10.1128/MRA.00165-21. PMID: 33664152; PMCID: PMC7936632.
Copy Download .nbib Format: NLM
Participating in a vaccine trial for COVID-19 in Senegal: trust and information.

Human vaccines & immunotherapeutics

Ridde V, Ba MF, Gaye I, Diallo AI, Bonnet E, Faye A.
PMID: 34280070
Hum Vaccin Immunother. 2021 Jul 19;1-6. doi: 10.1080/21645515.2021.1951097. Epub 2021 Jul 19.

This research aims to understand the level and determinants of people's willingness to participate in a vaccine trial for COVID-19 in Senegal. We conducted a telephone survey among a marginal quota sample of 607 people over 18 years of...

Cite
Ridde V, Ba MF, Gaye I, et al. Participating in a vaccine trial for COVID-19 in Senegal: trust and information. Hum Vaccin Immunother. 2021;1-6doi: 10.1080/21645515.2021.1951097.
Ridde, V., Ba, M. F., Gaye, I., Diallo, A. I., Bonnet, E., & Faye, A. (2021). Participating in a vaccine trial for COVID-19 in Senegal: trust and information. Human vaccines & immunotherapeutics, 1-6. https://doi.org/10.1080/21645515.2021.1951097
Ridde, V, et al. "Participating in a vaccine trial for COVID-19 in Senegal: trust and information." Human vaccines & immunotherapeutics vol. (2021): 1-6. doi: https://doi.org/10.1080/21645515.2021.1951097
Ridde V, Ba MF, Gaye I, Diallo AI, Bonnet E, Faye A. Participating in a vaccine trial for COVID-19 in Senegal: trust and information. Hum Vaccin Immunother. 2021 Jul 19;1-6. doi: 10.1080/21645515.2021.1951097. Epub 2021 Jul 19. PMID: 34280070.
Copy Download .nbib Format: NLM
Rehabilitation after critical illness-don't overlook technological and social factors.

BMJ (Clinical research ed.)

Coughlan C, Ranisz W, Leon-Villapolas C, Newey V, Boynton C, Corner E, Sturmey G, Wiltshire M, Brett S.
PMID: 34099501
BMJ. 2021 Jun 07;373:n1403. doi: 10.1136/bmj.n1403.

No abstract available.

Cite
Coughlan C, Ranisz W, Leon-Villapolas C, et al. Rehabilitation after critical illness-don't overlook technological and social factors. BMJ. 2021;373:n1403doi: 10.1136/bmj.n1403.
Coughlan, C., Ranisz, W., Leon-Villapolas, C., Newey, V., Boynton, C., Corner, E., Sturmey, G., Wiltshire, M., & Brett, S. (2021). Rehabilitation after critical illness-don't overlook technological and social factors. BMJ (Clinical research ed.), 373n1403. https://doi.org/10.1136/bmj.n1403
Coughlan, Charles, et al. "Rehabilitation after critical illness-don't overlook technological and social factors." BMJ (Clinical research ed.) vol. 373 (2021): n1403. doi: https://doi.org/10.1136/bmj.n1403
Coughlan C, Ranisz W, Leon-Villapolas C, Newey V, Boynton C, Corner E, Sturmey G, Wiltshire M, Brett S. Rehabilitation after critical illness-don't overlook technological and social factors. BMJ. 2021 Jun 07;373:n1403. doi: 10.1136/bmj.n1403. PMID: 34099501.
Copy Download .nbib Format: NLM
Coding practice in national and regional kidney biopsy registries.

BMC nephrology

Dendooven A, Peetermans H, Helbert M, Nguyen TQ, Marcussen N, Nagata M, Gesualdo L, Perkowska-Ptasinska A, Capusa C, López-Gómez JM, Geddes C, Abdul-Hamid MA, Segelmark M, Yahya R, Garau M, Villanueva R, Dorman A, Barbour S, Cornet R, Hopfer H, Amann K, Leh S.
PMID: 34030637
BMC Nephrol. 2021 May 24;22(1):193. doi: 10.1186/s12882-021-02365-3.

BACKGROUND: Kidney biopsy registries all over the world benefit research, teaching and health policy. Comparison, aggregation and exchange of data is however greatly dependent on how registration and coding of kidney biopsy diagnoses are performed. This paper gives an...

Cite
Dendooven A, Peetermans H, Helbert M, et al. Coding practice in national and regional kidney biopsy registries. BMC Nephrol. 2021;22(1):193doi: 10.1186/s12882-021-02365-3.
Dendooven, A., Peetermans, H., Helbert, M., Nguyen, T. Q., Marcussen, N., Nagata, M., Gesualdo, L., Perkowska-Ptasinska, A., Capusa, C., López-Gómez, J. M., Geddes, C., Abdul-Hamid, M. A., Segelmark, M., Yahya, R., Garau, M., Villanueva, R., Dorman, A., Barbour, S., Cornet, R., Hopfer, H., Amann, K., Leh, S. (2021). Coding practice in national and regional kidney biopsy registries. BMC nephrology, 22(1), 193. https://doi.org/10.1186/s12882-021-02365-3
Dendooven, Amélie, et al. "Coding practice in national and regional kidney biopsy registries." BMC nephrology vol. 22,1 (2021): 193. doi: https://doi.org/10.1186/s12882-021-02365-3
Dendooven A, Peetermans H, Helbert M, Nguyen TQ, Marcussen N, Nagata M, Gesualdo L, Perkowska-Ptasinska A, Capusa C, López-Gómez JM, Geddes C, Abdul-Hamid MA, Segelmark M, Yahya R, Garau M, Villanueva R, Dorman A, Barbour S, Cornet R, Hopfer H, Amann K, Leh S. Coding practice in national and regional kidney biopsy registries. BMC Nephrol. 2021 May 24;22(1):193. doi: 10.1186/s12882-021-02365-3. PMID: 34030637; PMCID: PMC8146626.
Copy Download .nbib Format: NLM
Digital health in oncology in Africa: A scoping review and cross-sectional survey.

International journal of medical informatics

Kabukye JK, Kakungulu E, Keizer N, Cornet R.
PMID: 34929545
Int J Med Inform. 2021 Dec 11;158:104659. doi: 10.1016/j.ijmedinf.2021.104659. Epub 2021 Dec 11.

BACKGROUND: Low- and middle-income countries, especially in Africa, face a growing cancer burden. Adoption of digital health solutions has the potential to improve cancer care delivery and research in these countries. However, the extent of implementation and the impact...

Cite
Kabukye JK, Kakungulu E, Keizer N, et al. Digital health in oncology in Africa: A scoping review and cross-sectional survey. Int J Med Inform. 2021;158:104659doi: 10.1016/j.ijmedinf.2021.104659.
Kabukye, J. K., Kakungulu, E., Keizer, N., & Cornet, R. (2021). Digital health in oncology in Africa: A scoping review and cross-sectional survey. International journal of medical informatics, 158104659. https://doi.org/10.1016/j.ijmedinf.2021.104659
Kabukye, Johnblack K, et al. "Digital health in oncology in Africa: A scoping review and cross-sectional survey." International journal of medical informatics vol. 158 (2021): 104659. doi: https://doi.org/10.1016/j.ijmedinf.2021.104659
Kabukye JK, Kakungulu E, Keizer N, Cornet R. Digital health in oncology in Africa: A scoping review and cross-sectional survey. Int J Med Inform. 2021 Dec 11;158:104659. doi: 10.1016/j.ijmedinf.2021.104659. Epub 2021 Dec 11. PMID: 34929545.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 292 entries